Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Perdoceo Education
PRDO
$2.03B
| $487K | ﹤0.01% |
56,068
-4,732
| -8% | -$43.5K |
|
|
ARRS
3377
CALL
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $487K | ﹤0.01% |
18,400
+16,200
| +736% | +$453K |
|
|
ISBC
3378
DELISTED
Investors Bancorp, Inc.
ISBC
| $486K | ﹤0.01% |
33,764
-7,633
| -18% | -$109K |
|
3379
PIMCO Dynamic Income Fund
PDI
$7.41B
| $485K | ﹤0.01% |
16,814
| – | – |
|
3380
PUT
Rambus
RMBS
$10.6B
| $485K | ﹤0.01% |
36,900
-2,900
| -7% | -$38.1K |
|
3381
CALL
iShares MSCI Australia ETF
EWA
$1.44B
| $484K | ﹤0.01% |
21,400
+9,300
| +77% | +$203K |
|
3382
Sasol
SSL
$7.24B
| $484K | ﹤0.01% |
16,474
+16,400
| +22,162% | +$479K |
|
|
WRI
3383
PUT
DELISTED
Weingarten Realty Investors
WRI
| $484K | ﹤0.01% |
+14,500
| New | +$506K |
|
3384
StoneX
SNEX
$8.07B
| $482K | ﹤0.01% |
64,213
+63,099
| +5,664% | +$468K |
|
3385
PUT
ServiceNow
NOW
$121B
| $481K | ﹤0.01% |
27,500
-511,500
| -95% | -$8.92M |
|
|
HOME
3386
DELISTED
At Home Group Inc.
HOME
| $480K | ﹤0.01% |
31,608
+26,639
| +536% | +$403K |
|
3387
CALL
Evolent Health
EVH
$404M
| $479K | ﹤0.01% |
+21,500
| New | +$413K |
|
|
EMLB
3388
DELISTED
iPath Long Enhanced MSCI Emerging Markets Index ETN
EMLB
| $479K | ﹤0.01% |
+9,974
| New | +$618K |
|
3389
Carlyle Group
CG
$17.6B
| $478K | ﹤0.01% |
30,013
+8,394
| +39% | +$138K |
|
3390
AtriCure
ATRC
$2.01B
| $477K | ﹤0.01% |
24,877
-513
| -2% | -$8.99K |
|
3391
PUT
Neurocrine Biosciences
NBIX
$16.2B
| $476K | ﹤0.01% |
11,000
-181,700
| -94% | -$7.78M |
|
|
NVO
3392
Novo Nordisk
NVO
$203B
| $476K | ﹤0.01% |
27,806
-34,824
| -56% | -$606K |
|
3393
CALL
ProShares UltraShort S&P500
SDS
$394M
| $475K | ﹤0.01% |
353
-1,094
| -76% | -$1.53M |
|
|
GMLP
3394
DELISTED
Golar LNG Partners LP
GMLP
| $475K | ﹤0.01% |
21,265
-19,885
| -48% | -$458K |
|
3395
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
| $474K | ﹤0.01% |
4,675
-3,040
| -39% | -$307K |
|
|
SHLD
3396
CALL
DELISTED
Sears Holding Corporation
SHLD
| $474K | ﹤0.01% |
41,300
-26,100
| -39% | -$218K |
|
3397
WIX.com
WIX
$2.55B
| $473K | ﹤0.01% |
6,965
-342
| -5% | -$20.1K |
|
3398
PUT
Newell Brands
NWL
$2.56B
| $472K | ﹤0.01% |
10,000
-25,100
| -72% | -$1.19M |
|
3399
CALL
Textron
TXT
$15.1B
| $471K | ﹤0.01% |
9,900
-26,300
| -73% | -$1.27M |
|
|
EGL
3400
DELISTED
Engility Holdings, Inc.
EGL
| $471K | ﹤0.01% |
16,306
+9,956
| +157% | +$304K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.